The Home Blood Pressure (BP) Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 2, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
End Stage Renal Disease on Dialysis
Interventions
OTHER

Dry weight target adjustment

Target dry weight will be adjusted every 2 weeks to reach the home or pre-dialysis systolic blood pressure target.

DRUG

Anti-hypertensive medications

Anti-hypertensive medications will be adjusted every 2 weeks to reach the home or pre-dialysis systolic blood pressure target. Adjustment of currently prescribed anti-hypertensive medications will be prioritized before starting new medications. Only standard anti-hypertensive medications will be used, such as RAAS inhibitors, beta-blockers, calcium channel blockers and diuretics.

Trial Locations (2)

94143

University of California San Francisco, San Francisco

98104

University of Washington, Seattle

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Washington

OTHER